UCB - Operating Profit

Stock Price
270.90
Daily Change
0.70 0.26%
Monthly
4.59%
Yearly
46.35%
Q1 Forecast
269.39

UCB reported EUR1B in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Alcon AG USD 332M 85M Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Amarin USD -1.7M 8.47M Sep/2025
argenx SE USD 349.97M 146.13M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR -543M 556M Sep/2025
Galapagos EUR -41.67M 15.36M Sep/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 2.57M Sep/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Orion EUR 328.2M 207.2M Dec/2025
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1B 678M Dec/2024
Unibail Rodamco EUR 946.5M 483.8M Jun/2025